CFDE Data Portal | Search ARHGAP44

	Label	Description
	ARHGAP44 Gene (Entity type)	ENSG00000006740 - Rho GTPase activating protein 44
	ARHGAP44 associations Collection (Entity type)	Associations for ARHGAP44_associations
	ARHGAP44 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	ARHGAP44-AS1 Gene (Entity type)	ENSG00000265489 - ARHGAP44 and MYOCD antisense RNA 1
	GSE144443 0 V 6 NICOTINAMIDE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 2 V 5 PACLITAXEL HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE228727 2 V 1 DAPAGLIFLOZIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE128730 3 V 5 NERATINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE158834 ADIPOR2 knockout HEK293 1 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 6 V 10 CRIZOTINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

ARHGAP44

ENSG00000006740 - Rho GTPase activating protein 44

ARHGAP44 associations

Associations for ARHGAP44_associations

ARHGAP44 associations.tsv

A file from IDG as part of the Harmonizome project

ARHGAP44-AS1

ENSG00000265489 - ARHGAP44 and MYOCD antisense RNA 1

GSE144443 0 V 6 NICOTINAMIDE MOUSE UP

A Gene Set from LINCS

GSE172016 2 V 5 PACLITAXEL HUMAN UP

A Gene Set from LINCS

GSE228727 2 V 1 DAPAGLIFLOZIN MOUSE UP

A Gene Set from LINCS

GSE128730 3 V 5 NERATINIB HUMAN UP

A Gene Set from LINCS

GSE158834 ADIPOR2 knockout HEK293 1 v 6 human dn

A Gene Set from LINCS

GSE239844 6 V 10 CRIZOTINIB HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.